SMTL ID : 3hdn.1

Crystal structure of serum and glucocorticoid-regulated kinase 1 in complex with compound 2

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 3.10 Å

Oligo State

monomer

Ligands

1 x GMG: [4-(5-naphthalen-2-yl-1H-pyrrolo[2,3-b]pyridin-3-yl)phenyl]acetic acid(Non-covalent)

GMG.1: 13 residues within 4Å: Chain A: I.46, G.49, S.50, F.51, V.54, A.67, K.69, L.118, D.119, I.121, N.122, L.171, T.181 9 PLIP interactions: 9 interactions with chain A Hydrophobic interactions: A:I.46, A:V.54, A:L.171, A:T.181 Hydrogen bonds: A:S.50, A:F.51, A:D.119, A:I.121 Salt bridges: A:K.69

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Hammond, M. et al., Design and synthesis of orally bioavailable serum and glucocorticoid-regulated kinase 1 (SGK1) inhibitors. Bioorg.Med.Chem.Lett. (2009)

Release Date

2009-06-30

Peptides

Serine/threonine-protein kinase Sgk1: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Serine/threonine-protein kinase Sgk1

Related Entries With Identical Sequence